[PHD抑制剂对瘤微环境和瘤免疫反应的影响]
Shinji Matsunaga1, Shuhei Tomita1
1Department of Pharmacology, Osaka Metropolitan University Graduate School of Medicine.
概括
低氧诱导因子基酶 (HIF-PH) 抑制剂可以通过改变瘤透的巨细胞来抑制瘤生长. 需要进一步的研究来澄清这些抑制剂在癌症治疗中的风险和益处.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 催氧诱导因子酸酶 (HIF-PH) 抑制剂在临床上使用,来自日本的大量数据.
- HIF-PH 抑制剂可调高缺氧诱导因子 (HIF),这些因子在癌症中具有复杂的作用,可能通过免疫调节促进瘤进展或抑制瘤进展.
- HIF上调对瘤进展和免疫反应的精确体内影响仍然不清楚.
研究的目的:
- 研究HIF-PH抑制剂在癌症治疗中的治疗潜力.
- 阐明HIF-PH抑制剂影响瘤生长和免疫透的机制.
- 评估未来HIF-PH抑制剂在瘤学中的应用的风险和益处.
主要方法:
- 利用携带瘤的小鼠模型来评估HIF-PH抑制剂治疗的影响.
- 分析了瘤血管的变化和瘤生长动力学.
- 研究了瘤透的巨细胞在调解观察到的治疗效果中的作用.
主要成果:
- 用HIF-PH抑制剂治疗使瘤血管复原,并在体内抑制瘤生长.
- 这些效应归因于瘤透的巨细胞的调节.
- 在服用HIF-PH抑制剂后,巨体表现出改变的表型.
结论:
- HIF-PH 抑制剂通过促进瘤生长抑制,显示出作为抗癌剂的潜力.
- 该机制涉及瘤透的巨细胞的重编程,从而改善瘤血管化和减少瘤进展.
- 仔细考虑HIF的双重作用对于优化HIF-PH抑制剂的临床应用至关重要.
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:27Cytotoxic T Cells-mediated Immune Response
903
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
903